Chen Yuqing succeeds as Chairman of Fosun Pharma, completion of the business change of Fosun Pharma.

Tianyancha App shows that recently, Fosun Pharma had a change in its business registration. Wu Yifang has resigned as the legal representative and chairman, and has been replaced by Chen Yuqing. At the same time, there have been changes in some senior management positions. Shanghai Fosun Pharmaceutical Group Co., Ltd was established in May 1995 with a registered capital of approximately 2.67 billion RMB. Its business scope includes exporting the company's own products and related technologies, importing raw materials, machinery and equipment, instruments and accessories needed for production and research, etc. It is jointly owned by Shanghai Fosun High Technology Co., Ltd, HKSCC NOMINEES LIMITED, Hong Kong Central Clearing Limited, etc. According to previous media reports, Fosun Pharma announced that Wu Yifang will no longer serve as an executive director and chairman of Fosun Pharma, but will instead be a non-executive director. Chen Yuqing will be the chairman and executive director of Fosun Pharma.